Abstract:The COVID-19 pandemia due to the SARS-CoV-2 coronavirus, in its first 4 months since its outbreak, has to date reached more than 200 countries worldwide with more than 2 million confirmed cases (probably a much higher number of infected), and almost 200,000 deaths. Amplification of viral RNA by (real time) reverse transcription polymerase chain reaction (rRT-PCR) is the current gold standard test for confirmation of infection, although it presents known shortcomings: long turnaround times (3-4 hours to generate results), potential shortage of reagents, false-negative rates as large as 15-20%, the need for certified laboratories, expensive equipment and trained personnel. Thus there is a need for alternative, faster, less expensive and more accessible tests. We developed two machine learning classification models using hematochemical values from routine blood exams (namely: white blood cells counts, and the platelets, CRP, AST, ALT, GGT, ALP, LDH plasma levels) drawn from 279 patients who, after being admitted to the San Raffaele Hospital (Milan, Italy) emergency-room with COVID-19 symptoms, were screened with the rRT-PCR test performed on respiratory tract specimens. Of these patients, 177 resulted positive, whereas 102 received a negative response. We have developed two machine learning models, to discriminate between patients who are either positive or negative to the SARS-CoV-2: their accuracy ranges between 82% and 86%, and sensitivity between 92% e 95%, so comparably well with respect to the gold standard. We also developed an interpretable Decision Tree model as a simple decision aid for clinician interpreting blood tests (even off-line) for COVID-19 suspect cases. This study demonstrated the feasibility and clinical soundness of using blood tests analysis and machine learning as an alternative to rRT-PCR for identifying COVID-19 positive patients. This is especially useful in those countries, like developing ones, suffering from shortages of rRT-PCR reagents and specialized laboratories. We made available a Web-based tool for clinical reference and evaluation (This tool is available at https://covid19-blood-ml.herokuapp.com/).

An Explainable-AI approach for Diagnosis of COVID-19 using MALDI-ToF Mass Spectrometry

Novel application of automated machine learning with MALDI-TOF-MS for rapid high-throughput screening of COVID-19: a proof of concept

A Decision Support System for Diagnosis of COVID-19 from Non-COVID-19 Influenza-like Illness Using Explainable Artificial Intelligence

SG-APSIC1053: Detection of SARS-COV-2 in nasopharyngeal swags with MALDI-TOF MS and machine learning

Artificial intelligence for rapid identification of the coronavirus disease 2019 (COVID-19)

Detection of SARS-CoV-2 Infection in Human Nasopharyngeal Samples by Combining MALDI-TOF MS and Artificial Intelligence

An Explainable AI Approach for the Rapid Diagnosis of COVID-19 Using Ensemble Learning Algorithms

Artificial Intelligence-Enabled Rapid Diagnosis of COVID-19 Patients

Artificial Intelligence–enabled Rapid Diagnosis of Patients with COVID-19

Explainable artificial intelligence approaches for COVID-19 prognosis prediction using clinical markers

COVID-19 diagnosis from routine blood tests using artificial intelligence techniques

Detection of COVID-19 Using Protein Sequence Data via Machine Learning Classification Approach

Transparent and Accurate COVID-19 Diagnosis: Integrating Explainable AI with Advanced Deep Learning in CT Imaging

Detection of SARS-CoV-2 in nasal swabs using MALDI-MS

Identification of Endogenous Peptides in Nasal Swab Transport Media used in MALDI-TOF-MS Based COVID-19 Screening.

A review of explainable and interpretable AI with applications in COVID‐19 imaging

Rapid Detection of COVID-19 Using MALDI-TOF-Based Serum Peptidome Profiling

Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study

An Explainable AI System for Automated COVID-19 Assessment and Lesion Categorization from CT-scans

An Explainable Decision Support Framework for Differential Diagnosis Between Mild COVID-19 and Other Similar Influenzas

MALDI(+) FT-ICR Mass Spectrometry (MS) Combined with Machine Learning toward Saliva-Based Diagnostic Screening for COVID-19